BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 3598272)

  • 21. Colposcopy of adenocarcinoma in situ and invasive adenocarcinoma of the cervix.
    Lickrish GM; Colgan TJ; Wright VC
    Obstet Gynecol Clin North Am; 1993 Mar; 20(1):111-22. PubMed ID: 8332305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
    Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
    Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions.
    Nagai N; Oshita T; Murakami J; Ohama K
    Oncol Rep; 1999; 6(2):325-8. PubMed ID: 10022998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenocarcinoma in situ of the cervix: management and outcome.
    Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
    Rooker D; Baalbergen A; Helmerhorst TJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(17):977-80. PubMed ID: 18549169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe cervical glandular cell lesions with coexisting squamous cell lesions.
    van Aspert-van Erp AJ; Smedts FM; Vooijs GP
    Cancer; 2004 Aug; 102(4):218-27. PubMed ID: 15368313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of prospective cytological diagnoses of cervical intraepithelial neoplasia].
    Saks A; Kodric T; Novak S; Vlaisavljević V
    Jugosl Ginekol Opstet; 1983; 23(5-6):103-6. PubMed ID: 6678996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superficial endometriosis of the uterine cervix: a report of 20 cases of a process that may be confused with endocervical glandular dysplasia or adenocarcinoma in situ.
    Baker PM; Clement PB; Bell DA; Young RH
    Int J Gynecol Pathol; 1999 Jul; 18(3):198-205. PubMed ID: 12090586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diffusion weighted imaging features of normal uterine cervix and cervical carcinoma].
    Zhang Y; Liang BL; Gao L; Ye RX; Shen J; Zhong JL
    Ai Zheng; 2007 May; 26(5):508-12. PubMed ID: 17672942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
    Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
    Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Loss of beta 2 microglobulin from the surface of "dysplastic" and malignant epithelial cells of the uterine cervix].
    Tseleni-Balafouta S; Balafoutas AC; Paraskevakou H
    Zentralbl Gynakol; 1989; 111(11):744-8. PubMed ID: 2675495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cytological classification of precancer and cancer of the cervix uteri].
    Agamova KA; Nikitina NI; Gosh TE; Tikhomirova EE; Gladunova ZD
    Vopr Onkol; 1987; 33(5):54-9. PubMed ID: 3590668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytological diagnosis in dysplasia of the uterine cervix.
    Yajima A; Higashiiwai H; Sato A; Watanabe M; Mori T; Nasu I; Noda K
    Tohoku J Exp Med; 1979 Dec; 129(4):311-7. PubMed ID: 524354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cytologic charcteristics of histologic forms of cancer of the uterine cervix].
    Botnar' ER
    Arkh Patol; 1977; 39(3):56-63. PubMed ID: 871256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A, B & H isoantigens in cervical lesions.
    Bisht D; Misra V; Gupta SC; Mehrotra R; Garg S
    Indian J Pathol Microbiol; 1998 Jan; 41(1):11-4. PubMed ID: 9581070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histogenesis of cervical adenocarcinoma with reference to human papillomavirus-18 as a carcinogen.
    Okagaki T; Tase T; Twiggs LB; Carson LF
    J Reprod Med; 1989 Sep; 34(9):639-44. PubMed ID: 2553963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benign to malignant progression in cervical squamous epithelium.
    Ehrmann RL
    Compr Ther; 1996 Feb; 22(2):67-75. PubMed ID: 8689865
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of adenocarcinoma in situ (ACIS) of the uteri cervix--a clinical dilemma.
    Tay EH; Yew WS; Ho TH
    Singapore Med J; 1999 Jan; 40(1):36-9. PubMed ID: 10361484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimation of the duration of the preclinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening.
    Plaxe SC; Saltzstein SL
    Gynecol Oncol; 1999 Oct; 75(1):55-61. PubMed ID: 10502426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.